Loading...
Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization
Long‐term exposure to lipid‐lowering drugs might affect Parkinson's disease (PD) risk. We conducted Mendelian randomization analyses where genetic variants indexed expected effects of modulating lipid‐lowering drug targets on PD. Statin exposure was not predicted to increase PD risk, although r...
Na minha lista:
| Udgivet i: | Ann Neurol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7693098/ https://ncbi.nlm.nih.gov/pubmed/32841444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25880 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|